Hawaii Biotech, Inc.

CAGE Code: 0EAY9

NCAGE Code: 0EAY9

Status: Active

Type: Commercial Supplier

Dun & Bradstreet (DUNS): 113226823

CAGE 0EAY9 Hawaii Biotech, Inc.
CAGE 0EAY9 Hawaii Biotech, Inc.

Summary

Hawaii Biotech, Inc. is an Active Commercial Supplier with the Cage Code 0EAY9 and is tracked by Dun & Bradstreet under DUNS Number 113226823..

Address

650 Iwilei Rd
Ste 204
Honolulu HI 96817-5318
United States

Points of Contact

Hawaii Biotech, Inc. http://www.hibiotech.com/

Related Information

DUNS Report

Associated CAGE Codes People who viewed this 'CAGE Code' also viewed...

Best Instant Signs Pacific Sign And Graphics Ali'i Kai International Holding American Heart Assn Hawaii Affil Designs On Time George House Usa Inc Pacific Rim Productions Ltd Peacock Gaudio Sales And Marketing Versa Tec Co Gouvea's Inc J.T.E. Inc L. Kang Inc. Hawaii Integrated Inc Hpc Foods, Ltd. Island Coffee Co Johnson Joan M Co Mac Farms Of Hawaii Llc O K Distributors Pacific Poultry Co Ltd Island Banana Company Inc Dba Daily

CAGE Code FAQ Frequently Asked Questions (FAQ) for CAGE 0EAY9

What is CAGE Code 0EAY9?
0EAY9 is the unique identifier used by NATO Organizations to reference the physical entity known as Hawaii Biotech, Inc. located at 650 Iwilei Rd, Ste 204, Honolulu HI 96817-5318, United States.
Who is CAGE Code 0EAY9?
0EAY9 refers to Hawaii Biotech, Inc. located at 650 Iwilei Rd, Ste 204, Honolulu HI 96817-5318, United States.
Where is CAGE Code 0EAY9 Located?
CAGE Code 0EAY9 is located in Honolulu, HI, USA.

Contracting History for CAGE 0EAY9 Contracting History for CAGE 0EAY9 Most Recent 25 Records

75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
30 Jun 2023
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$26,031,163.00
75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
6 Sep 2023
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$26,031,163.00
75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
10 Jun 2021
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$24,029,922.00
75N93018C00023
Eo14042 - To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
10 Jun 2022
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$24,099,174.00
75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
27 Aug 2021
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$24,099,174.00
75N93018C00023
Eo14042 - To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
1 Dec 2021
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$24,099,174.00
75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
22 Jun 2022
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$24,099,174.00
75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
29 Nov 2022
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$24,099,174.00
75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
28 Apr 2023
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$26,238,984.00
75N93018C00023
To Develop A Small Molecule Drug Anti-Toxin Therapeutic To Treat Anthrax In Humans.
7 Jun 2021
National Institutes Of Health Niaid
Department Of Health And Human Services (Hhs)
$24,029,922.00